Adrenergic Antagonists
Showing 1 - 25 of 1,226
ß1-adrenergic Antagonists on Nociceptive-Level Index Variation
Completed
- Nociception During Anesthesia in Patients Taking β1-adrenergic Antagonist Chronic Treatment
- standardized noxious stimulus under general anesthesia.
-
Montréal-Est, Quebec, CanadaHopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montre
Aug 31, 2020
Atrial Fibrillation, Atrial Fibrillation New Onset, Atrial Fibrillation, Persistent Trial in Canada (Cryoballoon-based PVI,
Active, not recruiting
- Atrial Fibrillation
- +12 more
- Cryoballoon-based PVI
- Anti-Arrhythmic Drug Therapy
-
Calgary, Alberta, Canada
- +17 more
Aug 22, 2022
Sleep Deprivation, Sleep Wake Disorders, Sleep Trial in Copenhagen (Carvedilol 25mg, Placebo oral capsule)
Completed
- Sleep Deprivation
- +2 more
- Carvedilol 25mg
- Placebo oral capsule
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Nov 18, 2022
Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting
Withdrawn
- Pulmonary Disease, Chronic Obstructive
- Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
- Fluticasone furoate/umeclidinium/vilanterol
-
Waterbury, Connecticut
- +2 more
Apr 21, 2020
Insulin Resistance, Healthy, Obesity Trial in Nashville (Phentolamine, Saline, Sodium Nitroprusside)
Recruiting
- Insulin Resistance
- +2 more
- Phentolamine
- +2 more
-
Nashville, TennesseeAutonomic Dysfunction Center
Jan 2, 2023
Anesthesia Intubation Complication Trial in Zagazig (Nebulized Dexmedetomidine, Nebulized Lidocaine, Intravenous
Not yet recruiting
- Anesthesia Intubation Complication
- Nebulized Dexmedetomidine
- +3 more
-
Zagazig, Al-Sharkia, EgyptFaculty of medicine, Zagazig University
Jul 4, 2023
Renal Stone Trial in Cairo (Ureteral access sheath placement during flexible ureteroscope for renal stones)
Not yet recruiting
- Renal Stone
- Ureteral access sheath placement during flexible ureteroscope for renal stones
-
Cairo, EgyptUrology department - AlAzhar university
Apr 16, 2023
Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction Trial in New York (Beta blocker)
Recruiting
- Heart Failure
- +4 more
- Beta blocker
-
New York, New YorkWeill Cornell Medicine
Jan 31, 2023
Functional Endoscopic Sinus Surgery, Dexmedetomidine Trial in Tanta (intranasal dexmedetomidine group, intravouns
Recruiting
- Functional Endoscopic Sinus Surgery
- Dexmedetomidine
- intranasal dexmedetomidine group
- intravouns dexmedetomidine group
-
Tanta, ElGharbiaa, EgyptMohammad Fouad Algyar
Jan 8, 2023
Dilated Cardiomyopathies, Idiopathic, Heart Failure, Systolic, Ventricular Remodeling Trial in Aurora, Columbus (Ivabradine,
Active, not recruiting
- Dilated Cardiomyopathies, Idiopathic
- +3 more
- Ivabradine
- Placebo
-
Aurora, Colorado
- +1 more
Oct 31, 2022
Nocturia Trial in Birmingham, Atlanta (Behavioral, tamsulosin (alpha-adrenergic antagonist medication), )
Completed
- Nocturia
- Behavioral
- +2 more
-
Birmingham, Alabama
- +1 more
Sep 9, 2021
Glaucoma, OHT - Ocular Hypertension Trial in Rochester, Omaha, Columbus (Timolol 0.5% ophthalmic solution, Latanoprost 0.005%
Recruiting
- Glaucoma
- OHT - Ocular Hypertension
- Timolol 0.5% ophthalmic solution
- Latanoprost 0.005% Ophthalmic Solution
-
Rochester, Minnesota
- +2 more
Jul 15, 2022
Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)
Recruiting
- Plasma Cell Myeloma
- +3 more
- Behavioral Intervention
- +6 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Jul 5, 2022
Scoliosis Correction, Postoperative Analgesia, Esketamine Trial in Beijing (Esketamine)
Not yet recruiting
- Scoliosis Correction
- +4 more
-
Beijing, Beijing, ChinaBeijing University First Hospital
Oct 17, 2023
Lower Ureteric Stones, Medical Expulsive Therapy, Tadalafil Trial in Benha (Placebo, Silodosin, Tadalafil)
Completed
- Lower Ureteric Stones
- +3 more
- Placebo
- +3 more
-
Benha, EgyptBenha University Hospitals
Mar 29, 2023
Heart Failure Trial in Atlanta (Thyroid hormone T3, Control Group)
Recruiting
- Heart Failure
- Thyroid hormone T3
- Control Group
-
Atlanta, Georgia
- +1 more
Nov 14, 2022
Type 2 Diabetes Trial in Sherbrooke (Mirabegron, Bisoprolol Fumarate)
Completed
- Type 2 Diabetes
- Mirabegron
- Bisoprolol Fumarate
-
Sherbrooke, Quebec, CanadaCentre de recherche du CHUS
Oct 31, 2022
Measuring Analgesic Interventions
Recruiting
- Pain
-
Washington, District of ColumbiaChildren's National Health System
Jan 31, 2023
Symptomatic Parkinson Disease, REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease Trial in Los Angeles (Terazosin
Recruiting
- Symptomatic Parkinson Disease
- +2 more
- Terazosin therapy
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Aug 23, 2022
Atrial Fibrillation, Permanent Atrial Fibrillation Trial in Rud (Metoprolol, Diltiazem)
Completed
- Atrial Fibrillation
- Permanent Atrial Fibrillation
-
Rud, Akershus, NorwayVestre Viken Hospital Trust, Baerum Hospital
Jan 4, 2022
Brachial Plexus Block, Dexmedetomidine, Dexamethasone Trial in Kathmandu (adding Dexmedetomidine and dexamethasone to
Completed
- Brachial Plexus Block
- +3 more
- adding Dexmedetomidine and dexamethasone to bupivacaine in USG guided supraclavicular brachial plexus block.
-
Kathmandu, Bagmati, NepalTribhuvan University Teaching Hospital
Jul 16, 2022
Falls in Older Adults: Analysis of World Health Organization
Completed
- Antidepressants Causing Adverse Effects in Therapeutic Use
- Fall
- Antidepressive Agents
-
Caen, Normandie, FranceCaen University Hospital, Department of Pharmacology
Nov 24, 2022
Heart Failure Trial (SGLT2i, beta blocker, ARNI, MRA, MTD, Education-First)
Not yet recruiting
- Heart Failure
- SGLT2i, beta blocker, ARNI, MRA, MTD
- Education-First
- (no location specified)
Feb 9, 2023
Acute Coronary Syndrome Trial in Naples (Carvedilol, Metoprolol)
Completed
- Acute Coronary Syndrome
-
Naples, ItalyFederico II University of Naples
Mar 15, 2022
Delirium Trial in Birmingham (Guanfacine, Placebo)
Recruiting
- Delirium
- Guanfacine
- Placebo
-
Birmingham, AlabamaUniversity of Alabama at Birmingham Hospital
Nov 17, 2021